Abstract:Misfolding of superoxide dismutase-1 (SOD1) is a pathological hallmark of amyotrophic lateral sclerosis (ALS) with SOD1 mutations. The development of antibodies specific for misfolded SOD1 deepens our understanding of how the protein participates in ALS pathogenesis. Since the term "misfolding" refers to various disordered conformers other than the natively folded one, which misfolded species are recognized by specific antibodies should be determined. Here, we molecularly characterized the recognition by MS785-MS27, an antibody cocktail experimentally confirmed to recognize over 100 ALS-linked SOD1 mutants. Indirect ELISA revealed that the antibody cocktail recognized Zn-deficient wild-type and mutated SOD1 species. It also recognized conformation-disordered wild-type and mutated SOD1 species, such as unfolded and oligomeric forms, but had less affinity for the aggregated form. Antibody-reactive SOD1 exhibited cytotoxicity to a motor neuron cell model, which was blocked by Zn treatment with Zn-deficient SOD1. Immunohistochemistry revealed antibody-reactive SOD1 mainly in spinal motor neurons of SOD1G93A mice throughout the disease course, and the distribution after symptomatic stages differed from that of other misfolded SOD1 species. This suggests that misfolded/non-native SOD1 species exist as heterogeneous populations. In conclusion, MS785-MS27 recognizes various conformation-disordered SOD1 species lacking the Zn ion.

What problem does this paper attempt to address?

The problems that this paper attempts to solve are: **To clarify the recognition characteristics of the MS785 - MS27 antibody cocktail for different conformationally abnormal SOD1 (superoxide dismutase 1) species, especially the performance of these species in the absence of zinc ions (Zn - deficient) and their relationship with the pathological process of amyotrophic lateral sclerosis (ALS)**. Specifically, the research aims to: 1. **Characterize the recognition ability of the MS785 - MS27 antibody cocktail for various SOD1 species at the molecular level**: - Confirm whether the antibody can recognize wild - type SOD1 and mutant SOD1 lacking zinc ions. - Investigate the reactivity of the antibody to SOD1 species with different conformational abnormalities (such as unfolded, oligomeric and aggregated forms). 2. **Explore whether these recognized SOD1 species are cytotoxic**: - Verify through cell experiments whether the SOD1 species recognized by MS785 - MS27 are toxic to the motor neuron cell model (NSC - 34 cells). - Investigate whether zinc ion supplementation can reverse this cytotoxicity. 3. **Analyze the distribution of the SOD1 species recognized by MS785 - MS27 in the ALS mouse model**: - Observe the localization of these SOD1 species in the spinal cord of G93A SOD1 transgenic mice and their changes with the disease process by immunofluorescence techniques. ### Main findings - **The MS785 - MS27 antibody cocktail specifically recognizes SOD1 species lacking zinc ions**, including wild - type and multiple ALS - related mutant SOD1. - **The antibody has a strong reactivity to the unfolded and oligomeric forms of SOD1**, but has a lower affinity for the aggregated form of SOD1. - **The SOD1 species recognized by MS785 - MS27 are toxic to NSC - 34 cells**, and this toxicity can be alleviated by zinc ion supplementation. - **In G93A SOD1 mice, the SOD1 species recognized by MS785 - MS27 are mainly distributed in the spinal cord motor neurons**, and their distribution changes with the progress of the disease. Through these studies, the authors hope to better understand the role of the SOD1 protein in the ALS pathological process and provide new insights for the development of treatment strategies for SOD1 - related ALS.

MS785-MS27 Reactive Misfolded/Non-Native Zn-Deficient SOD1 Species Exhibit Cytotoxicity and Adopt Heterozygous Conformations in Motor Neurons

Mutations in SOD1 associated with amyotrophic lateral sclerosis cause novel protein interactions

Engineering a monobody specific to monomeric Cu/Zn‐superoxide dismutase associated with amyotrophic lateral sclerosis

SOD1-interacting proteins: Roles of aggregation cores and protein degradation systems

Heat-shock protein 105 interacts with and suppresses aggregation of mutant Cu/Zn superoxide dismutase: clues to a possible strategy for treating ALS

Implications of ALS-Associated Mutations on Biochemical and Biophysical Features of hSOD1 and Aggregation Formation

Amyloidogenic regions in beta-strands II and III modulate the aggregation and toxicity of SOD1 in living cells

Exposure of a cryptic Hsp70 binding site determines the cytotoxicity of the ALS-associated SOD1-mutant A4V

Accumulation of misfolded SOD1 outlines distinct patterns of motor neuron pathology and death during disease progression in a SOD1G93A mouse model of amyotrophic lateral sclerosis

Amyloid fibril structures and ferroptosis activation induced by ALS-causing SOD1 mutations

Comprehensive in silico analysis and molecular dynamics of the superoxide dismutase 1 (SOD1) variants related to amyotrophic lateral sclerosis

Altered SOD1 maturation and post-translational modification in amyotrophic lateral sclerosis spinal cord

Disulfide‐mediated oligomerization of mutant Cu/Zn‐superoxide dismutase associated with canine degenerative myelopathy

Tryptophan residues in TDP-43 and SOD1 modulate the cross-seeding and toxicity of SOD1

Mass spectrometry imaging of SOD1 protein-metal complexes in SOD1G93A transgenic mice implicates demetalation with pathology

SOD1 exhibits allosteric frustration to facilitate metal binding affinity

A novel SOD1-ALS mutation separates central and peripheral effects of mutant SOD1 toxicity

Elucidation of the Molecular Characteristics of Wild-Type and ALS-Linked Mutant SOD1 Using the NanoLuc Complementation Reporter System

Detection the mutated protein aggregation and mitochondrial function in fibroblasts from amyotrophic lateral sclerosis patients with SOD1 gene mutations

High molecular weight complexes of mutant superoxide dismutase 1: age-dependent and tissue-specific accumulation